 |
|
|
|
|
|
|
|
 |
Results for 'Nitric Oxide' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Nitric Oxide
Therapeutics, Markets and Companies
|
September 2008 |
£1005 |
100 % |
Nitromed, Inc
Premium Company Profile
|
December 2007 |
£265 |
38.5 % |
Free Radicals in Ophthalmic Disorders
|
March 2008 |
£256 |
35 % |
Pain Therapeutics
Drugs, Markets and Companies
|
September 2008 |
£1075 |
18 % |
Human Embryo Evaluation and Selection
|
August 2007 |
£199.95 |
11.2 % |
Textbook of Interventional Cardiovascular Pharmacology
|
April 2007 |
£140 |
7.7 % |
Pipeline Insight: Heart failure Week pipeline dominated by new indications and add-on diuretics
|
August 2007 |
£6000 |
5.95 % |
Medical Device Coatings
|
April 2006 |
£3255 |
5.25 % |
Alzheimer disease
new drugs, markets and companies
|
September 2008 |
£1880 |
4.55 % |
Pipeline Insight: Migraine
Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries
|
December 2006 |
£6000 |
4.55 % |
Cardiovascular Drug Delivery
Technologies, markets and companies
|
September 2008 |
£1475 |
4.55 % |
Novel Targets in Drug Discovery
A new era in therapy
|
April 2004 |
£595 |
4.2 % |
Immunomodulators
Therapeutic Needs, Pipelines & Prospects
|
August 2007 |
£1495 |
4.2 % |
Transdermal Drug Delivery
Technologies, Markets, and Companies
|
September 2008 |
£1675 |
3.5 % |
Stakeholder Insight
Asthma - over-Prescribing Is Common in Intermittent and Mild Forms of Asthma
|
July 2008 |
£7600 |
2.8 % |
Cell Therapy
Technologies, Markets and Companies
|
September 2008 |
£3020 |
2.45 % |
Drug Delivery in Central Nervous System Diseases
technologies,markets and companies
|
September 2008 |
£900 |
2.1 % |
Drug Delivery in Cancer
Technologies, Markets and Companies
|
September 2008 |
£2010 |
2.1 % |
Proteomics
Technologies, Markets and Companies
|
September 2008 |
£2345 |
1.75 % |
|
|
|
|
